Alan Moses

Alan Moses

Director/Board Member at BIOMX INC.

Net worth: 1 050 $ as of 2024-02-28

76 year
Consumer Services
Health Technology
Commercial Services

Profile

Alan C.
Moses
is on the board of Steno Diabetes Center A, BiomX, Inc. and Chemomab Therapeutics Ltd.
In his past career Dr. Moses held the position of Global Chief Medical Officer & Senior VP at Novo Nordisk, Inc., Fellow at American College of Physicians, Inc., Chief Medical Officer & Senior Vice President for Joslin Diabetes Center, Inc., Professor at Harvard University and Professor at Harvard Medical School.
Dr. Moses received an undergraduate degree from Duke University and a doctorate from Washington University in St. Louis.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-07-24 5,000 ( 0.01% ) 1 050 $ 2024-02-28
2023-03-15 0 ( -.--% ) - $ 2024-02-28

Alan Moses active positions

CompaniesPositionStart
BIOMX INC. Director/Board Member 2020-10-01
CHEMOMAB THERAPEUTICS LTD. Director/Board Member 2021-03-15
Steno Diabetes Center A/S Director/Board Member -
All active positions of Alan Moses

Former positions of Alan Moses

CompaniesPositionEnd
Harvard Medical School Corporate Officer/Principal 2005-12-31
Chief Tech/Sci/R&D Officer 2003-12-31
Director/Board Member -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Alan Moses's experience

Training of Alan Moses

Washington University in St. Louis Doctorate Degree
Duke University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alan Moses's experience

Connections

100 +

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BIOMX INC.

Health Technology

CHEMOMAB THERAPEUTICS LTD.

Health Technology

Private companies5

Commercial Services

Health Technology

Commercial Services

Health Technology

Steno Diabetes Center A/S

See company connections
  1. Stock
  2. Insiders
  3. Alan Moses